Cite
MLA Citation
Naoki Takegawa et al.. “[fam‐] trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression level rather than on HER2 amplification.” International journal of cancer, vol. 145, no. 12, 2019, pp. 3414–3424. http://access.bl.uk/ark:/81055/vdc_100093258165.0x000061